HeC will help optimize therapeutic benefits of care plans for patients with chronic diseases such as diabetes by improving compliance, communication and feedback.
ALRT chairman and CEO Sidney Chan said Mantra Healthcare Solutions’ ability of establishing sustainable use will be key to the successful launch of HeC.
"Their proven track record and extensive relationships in the various health arenas will pave the way for accelerated penetration of HeC into the emerging market of in-home patient-focused chronic disease management," Chan said.
Mantra Healthcare Solutions president said in a clinical trial using HeC as the platform for intensive blood glucose control, average A1c of the participants was reduced from 8.8% to 7.6% over a six month period.
"As pay for performance programs are being implemented by Medicare and private insurers, HeC provides a necessary tool needed by hospitals and doctors to efficiently manage their patients to improve outcomes and maximize reimbursements," he said.
